HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sonia Berrih-Aknin Selected Research

Cholinergic Receptors

1/2022Myasthenia Gravis: An Acquired Interferonopathy?
10/2020Decreased expression of miR-29 family associated with autoimmune myasthenia gravis.
1/2020Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.
1/2019Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis.
1/2019The Muscle Is Not a Passive Target in Myasthenia Gravis.
6/2018Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues.
1/2018An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients.
1/2018Thymus involvement in early-onset myasthenia gravis.
2/2017Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.
2/2017Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sonia Berrih-Aknin Research Topics

Disease

53Myasthenia Gravis
01/2022 - 07/2003
29Autoimmune Diseases (Autoimmune Disease)
01/2022 - 07/2003
9Thymus Hyperplasia
01/2018 - 05/2005
7Inflammation (Inflammations)
01/2019 - 05/2007
6Thymoma (Thymic Carcinoma)
01/2022 - 08/2003
5Hyperplasia
10/2020 - 12/2006
5Neuromuscular Diseases (Neuromuscular Disease)
01/2019 - 10/2009
4Muscle Weakness
01/2021 - 08/2014
4Virus Diseases (Viral Diseases)
01/2017 - 07/2013
2Acquired Immunodeficiency Syndrome (AIDS)
01/2018 - 08/2014
2Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis)
02/2011 - 03/2010
1Intellectual Disability (Idiocy)
11/2021
1Disease Progression
01/2018
1Fatigue
01/2018
1Thyroiditis
01/2017
1Graves Disease (Basedow Disease)
01/2017
1Thyroid Diseases (Thyroid Disease)
01/2017
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2017
1Teratoma (Teratoid Tumor)
12/2014
1Myositis (Idiopathic Inflammatory Myopathies)
10/2014
1Infections
08/2014
1Papillomavirus Infections
08/2014
1Epstein-Barr Virus Infections
01/2011
1Colonic Neoplasms (Colon Cancer)
06/2008
1Neoplasms (Cancer)
06/2008
1Muscular Atrophy (Muscle Atrophy)
08/2006

Drug/Important Bio-Agent (IBA)

33Cholinergic ReceptorsIBA
01/2022 - 07/2003
30AntibodiesIBA
01/2022 - 07/2003
18AutoantibodiesIBA
10/2020 - 07/2003
6Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2005
4Interferon Type IIBA
01/2022 - 08/2014
4Biological ProductsIBA
01/2020 - 06/2008
4Interleukin-17 (Interleukin 17)IBA
01/2019 - 12/2012
3Estrogens (Estrogen)FDA Link
03/2020 - 04/2016
3MicroRNAs (MicroRNA)IBA
06/2018 - 10/2013
3ChemokinesIBA
01/2018 - 08/2014
3AutoantigensIBA
01/2018 - 05/2005
3CytokinesIBA
01/2018 - 05/2005
3Double-Stranded RNA (RNA, Double Stranded)IBA
01/2017 - 02/2013
3DNA (Deoxyribonucleic Acid)IBA
08/2014 - 06/2007
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2014 - 02/2005
3Phosphotransferases (Kinase)IBA
10/2013 - 03/2005
3muskIBA
03/2011 - 03/2005
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2018 - 02/2017
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2014
2InterferonsIBA
01/2018 - 02/2017
2Hormones (Hormone)IBA
01/2018 - 08/2014
2Interleukin-6 (Interleukin 6)IBA
01/2018 - 01/2015
2Toll-Like Receptors (Toll-Like Receptor)IBA
02/2017 - 07/2013
2AntigensIBA
02/2017 - 01/2017
2Complement System Proteins (Complement)IBA
10/2013 - 09/2007
2myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA
10/2013 - 08/2006
15' Untranslated Regions (5' UTR)IBA
11/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Acetylcholine (Acetylcholine Chloride)FDA Link
01/2020
1Interleukin-23 (Interleukin 23)IBA
01/2019
1Interleukin-12 (IL 12)IBA
01/2018
1Humanized Monoclonal AntibodiesIBA
01/2018
1Choline (Choline Chloride)IBA
12/2017
1Poly I-CIBA
01/2017
1Therapeutic UsesIBA
01/2017
1Toll-Like Receptor AgonistsIBA
01/2017
1CortactinIBA
10/2014
1Protein Kinases (Protein Kinase)IBA
08/2014
1Vitamin DFDA LinkGeneric
08/2014
1Interferon-betaIBA
08/2014
1Toll-Like Receptor 3IBA
08/2014
1Neutralizing AntibodiesIBA
08/2014
1ErbB Receptors (EGF Receptor)IBA
03/2011
1Epstein-Barr virus encoded RNA 1IBA
01/2011
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
03/2010
1Peptides (Polypeptides)IBA
06/2008
1RNA Precursors (Precursor, mRNA)IBA
06/2008
1Pharmaceutical PreparationsIBA
06/2007
1AcetylcholinesteraseIBA
05/2007
1Cholinergic Agents (Cholinergics)IBA
05/2007
1CC ChemokinesIBA
12/2006
1LigandsIBA
12/2006
1Chemokine CXCL13IBA
07/2006
1VaccinesIBA
07/2005
1Estrogen ReceptorsIBA
05/2005
1CXCR3 ReceptorsIBA
05/2005
1N 30IBA
03/2005
1micaIBA
08/2003
1HLA-DR3 Antigen (HLA DR3 Antigen)IBA
07/2003
1Thomsen-Friedenreich antibodiesIBA
07/2003

Therapy/Procedure

6Therapeutics
11/2018 - 07/2006
5Thymectomy
01/2019 - 12/2006
2Activities of Daily Living (ADL)
01/2021 - 01/2018
1Injections
01/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
07/2013
1Immunotherapy
06/2007
1Plasma Exchange
08/2006